Market Cap 26.67M
Revenue (ttm) 0.00
Net Income (ttm) -9.47M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 255,300
Avg Vol 159,172
Day's Range N/A - N/A
Shares Out 17.43M
Stochastic %K 70%
Beta 1.16
Analysts Strong Sell
Price Target $6.50

Company Profile

NanoViricides, Inc., a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company's product portfolio includes NV-387 drug candidate developed for RSV and influenza indications and has completed phase 1a/1b human clinical trial for the evaluation of safety and tolerability; NV-387 as an active ingredient of drug product formulations for the treatment of COVID infections comprising NV-CoV-2 Oral Syrup and NV-CoV-...

Industry: Biotechnology
Sector: Healthcare
Phone: 203 937 6137
Address:
1 Controls Drive, Shelton, United States
STRAYNUT
STRAYNUT Oct. 25 at 7:33 PM
$NNVC Short Interest (10/15/25) Shares Sold Short 46,270 Change from Last -21.11% Percent of Float 0.28% https://www.wsj.com/market-data/quotes/NNVC
0 · Reply
drkazmd65
drkazmd65 Oct. 24 at 3:57 PM
$NNVC - Alrighty Diwan,... Get something moving already.
0 · Reply
NVDAMillionaire
NVDAMillionaire Oct. 23 at 6:27 PM
$NNVC Excellent article that nails exactly where NNVC stands right now. So if you want to update your NNVC knowledge or get acquainted with NNVC, this is a must read. https://beyondspx.com/quote/NNVC/analysis/nanoviricides-unlocking-antiviral-revolution-with-host-mimetic-nanomedicine
0 · Reply
MahiMe
MahiMe Oct. 22 at 12:46 PM
$NNVC $NNVC In Treating Measles Infection, NV-387 Showed Strong Antiviral Activity, and Significantly, Protected Lungs from Damage, Describes NanoViricides https://www.stocktitan.net/news/NNVC/in-treating-measles-infection-nv-387-showed-strong-antiviral-oasi8vzsyxk7.html
0 · Reply
tomzprofit
tomzprofit Oct. 21 at 10:33 PM
0 · Reply
tomzprofit
tomzprofit Oct. 21 at 10:30 PM
0 · Reply
Love1010
Love1010 Oct. 21 at 10:02 PM
$NNVC someone is high on crack
0 · Reply
STRAYNUT
STRAYNUT Oct. 21 at 11:53 AM
$NNVC A Measles Drug with Strong Activity without Toxicity Can Be Available Now for Emergency Use, Says NanoViricides - NV-387 Broad-Spectrum Antiviral with Activity Against Measles Virus https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/a-measles-drug-with-strong-activity-without-toxicity-can-be-available-1089144
0 · Reply
Winning_calls
Winning_calls Oct. 20 at 2:35 AM
$NNVC pick me up @ $1.53
0 · Reply
Another_Voice
Another_Voice Oct. 19 at 6:24 PM
@lecorb
1 · Reply
Latest News on NNVC
NanoViricides, Inc. Has Filed its Annual Report

Sep 30, 2025, 8:45 AM EDT - 25 days ago

NanoViricides, Inc. Has Filed its Annual Report


NanoViricides Measles Drug Development Animal Study is Imminent

Jun 4, 2025, 6:55 AM EDT - 5 months ago

NanoViricides Measles Drug Development Animal Study is Imminent


NanoViricides, Inc. Has Filed its Quarterly Report

Feb 19, 2025, 6:30 AM EST - 8 months ago

NanoViricides, Inc. Has Filed its Quarterly Report


NanoViricides Engages CRO for Phase II Clinical Trial

Jan 27, 2025, 6:30 AM EST - 9 months ago

NanoViricides Engages CRO for Phase II Clinical Trial


NanoViricides Has Filed its Quarterly Report

May 15, 2024, 6:30 AM EDT - 1 year ago

NanoViricides Has Filed its Quarterly Report


A Novel Broad-Spectrum Antiviral with Activity Against RSV

May 14, 2024, 6:30 AM EDT - 1 year ago

A Novel Broad-Spectrum Antiviral with Activity Against RSV


STRAYNUT
STRAYNUT Oct. 25 at 7:33 PM
$NNVC Short Interest (10/15/25) Shares Sold Short 46,270 Change from Last -21.11% Percent of Float 0.28% https://www.wsj.com/market-data/quotes/NNVC
0 · Reply
drkazmd65
drkazmd65 Oct. 24 at 3:57 PM
$NNVC - Alrighty Diwan,... Get something moving already.
0 · Reply
NVDAMillionaire
NVDAMillionaire Oct. 23 at 6:27 PM
$NNVC Excellent article that nails exactly where NNVC stands right now. So if you want to update your NNVC knowledge or get acquainted with NNVC, this is a must read. https://beyondspx.com/quote/NNVC/analysis/nanoviricides-unlocking-antiviral-revolution-with-host-mimetic-nanomedicine
0 · Reply
MahiMe
MahiMe Oct. 22 at 12:46 PM
$NNVC $NNVC In Treating Measles Infection, NV-387 Showed Strong Antiviral Activity, and Significantly, Protected Lungs from Damage, Describes NanoViricides https://www.stocktitan.net/news/NNVC/in-treating-measles-infection-nv-387-showed-strong-antiviral-oasi8vzsyxk7.html
0 · Reply
tomzprofit
tomzprofit Oct. 21 at 10:33 PM
0 · Reply
tomzprofit
tomzprofit Oct. 21 at 10:30 PM
0 · Reply
Love1010
Love1010 Oct. 21 at 10:02 PM
$NNVC someone is high on crack
0 · Reply
STRAYNUT
STRAYNUT Oct. 21 at 11:53 AM
$NNVC A Measles Drug with Strong Activity without Toxicity Can Be Available Now for Emergency Use, Says NanoViricides - NV-387 Broad-Spectrum Antiviral with Activity Against Measles Virus https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/a-measles-drug-with-strong-activity-without-toxicity-can-be-available-1089144
0 · Reply
Winning_calls
Winning_calls Oct. 20 at 2:35 AM
$NNVC pick me up @ $1.53
0 · Reply
Another_Voice
Another_Voice Oct. 19 at 6:24 PM
@lecorb
1 · Reply
SPACEDAD
SPACEDAD Oct. 17 at 6:32 PM
$NNVC $RVP $ATGN all look tasty to buy here to me. On close watch. $TXMD at $1.16 is already paying off.
0 · Reply
lecorb
lecorb Oct. 17 at 3:27 PM
$NNVC $XRTX $RANI $ARTV $VHC I'm going to start blocking the damn piranhas. They're worse than flies. There are many companies on the decline with leverage for a justifiable reason, but they're piranhas and don't even respect themselves. The block has already started. I prefer fewer followers than these scavengers.
0 · Reply
lecorb
lecorb Oct. 17 at 2:52 PM
$NNVC Push Baby!
0 · Reply
CalculatedSwing
CalculatedSwing Oct. 17 at 2:32 PM
0 · Reply
lecorb
lecorb Oct. 16 at 4:03 PM
@taxplanr $NNVC October 15, 2025 10:10 AM InvestorNewsBreaks - NanoViricides Featured in Analyst Report Highlighting Dual-Track Clinical Strategy for NV-387 NanoViricides, Inc. announced that Proactive Investors published an analyst research report detailing the Company’s dual-track clinical development strategy for NV-387, its broad-spectrum antiviral drug candidate targeting both MPox and respiratory viral infections, including influenza, coronaviruses, and RSV. The report notes NV-387’s nano-polymer micelle technology, which binds and neutralizes virus particles before they infect cells. Following completion of a Phase 1 safety and tolerability study in 2023, NanoViricides plans to initiate a Phase 2 trial for MPox in Congo by late 2025 or early 2026, with ethics approval already secured. The report also highlights potential U.S. biodefense funding opportunities through BARDA based on successful trial outcomes. To view the full press release, visit https://ibn.fm/ib5Cg
0 · Reply
lecorb
lecorb Oct. 16 at 3:46 PM
@taxplanr $NNVC $PFE $BNTX $JNS $MRK You did not understand my post, it is not because of BNTX , it is because of the interest of large companies in NNVC for their Viral work for Covid.
1 · Reply
lecorb
lecorb Oct. 16 at 1:34 PM
$NNVC $PFE $BNTX $JNS $MRK This Clinical-stage Biotech Company is Taking Its Revolutionary Platform to Help Eradicate Many Respiratory Viruses: a SINGLE drug treats RSV, FLU/Birdflu, long COVID plus monkey-pox & measles, and may even help lower the risk of metastatic cancer returning in patients following viral infections. https://profiles.smallcapsdaily.com/nnvc/?utm_source=interactiveoffers&utm_medium=email&utm_campaign=22032&utm_term=marketbeat.com&utm_content=59180&c=0&h=1&sub=&ax_09Am1=HC0HK&iocid=84ccb517e177a81f0eee5697b9e18c7e1caa7d70
0 · Reply
DARKP00L
DARKP00L Oct. 15 at 12:47 PM
$NNVC 08:47 on Oct. 15 2025 NanoViricides Reports That An Analyst Research Report Was Published On The Company That Explains Its Dual-Track Clinical Trials For NV-387 Targeting MPox And Respiratory Viruses #tradeideas
0 · Reply
CalculatedSwing
CalculatedSwing Oct. 13 at 5:12 PM
$NNVC 🚀 unleashing NV-387 Phase II beast mode: Ethics approval locked for MPox trials in DRC, eyeing ~$1B US stockpile jackpot! Phase I crushed with ZERO dropouts, measles animal study revving up—nanotech antiviral moonshot at $1.37? Analysts buzzing! Degen biotech squad: $OCGN $BTAI $TNXP $SINT – virus slayers & nano disruptors primed to explode! Load up! 🦠💉📈 #BiotechBulls #PennyVirals
0 · Reply
STRAYNUT
STRAYNUT Oct. 9 at 8:02 PM
$NNVC Short Interest (09/30/25) Shares Sold Short 58,654 Change from Last -74.71% Percent of Float 0.35% https://www.wsj.com/market-data/quotes/NNVC
0 · Reply
Camper_trader
Camper_trader Oct. 7 at 12:09 PM
$NNVC waste time buy plug much better
0 · Reply
BiotechBrawler
BiotechBrawler Oct. 5 at 2:02 PM
$NNVC Biotech speculation. Pre-revenue stage. Chart shows high risk/reward. No pattern recognition.
1 · Reply